// App-Quantinova.ai

: CD22 CAR Optimization for Improved in-Human Activity Following Inadequate CD22 CAR Activity in Phase 1 Clinical Trial PLAT-04

Researchers

Presenter

  • Corinne Summers

Principal Investigators

  • Blake Baxter

  • Colleen Annesley

  • Jason Yokoyama

  • Stephanie Rhea

  • Wenjun Huang

  • Ashley Wilson

  • Julie R. Park

  • Rimas J Orentas

  • Michael C. Jensen

  • Rebecca A Gardner

Medical Centers

  • Seattle Children's Therapeutics, Seattle Children's Research Institute, Seattle, WA

  • Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, WA

  • Seattle Children's Research Institute, Seattle

  • Seattle Children's Research Institute, Seattle, WA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Coxsackie Virus And Adenovirus Receptor

  • Epidermal growth factor receptor

  • Cluster of differentiation 8A

  • T cell activity

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Dose Response

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved